MacroGenics, Inc.

Healthcare

NASDAQ:MGNX · NASDAQ Global Select

Market Cap $262.52M Beta 1.20 P/E (TTM) -3.6

$4.13 +2.02%

+$0.08 today

52W Low $1.19High $4.64

Vol 0.96M · Avg 0.98M

EPS (TTM) -$1.11Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+212.88%

Period High

$4.53

Period Low

$1.19

Latest

$4.13

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Ovid Therapeutics Inc.

NASDAQ:OVID

$305.31M

Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

$259.77M

Shattuck Labs, Inc.

NASDAQ:STTK

$232.19M

Whitehawk Therapeutics Inc

NASDAQ:WHWK

$208.69M

Oramed Pharmaceuticals Inc.

NASDAQ:ORMP

$157.57M

InflaRx N.V.

NASDAQ:IFRX

$129.66M

Connect Biopharma Holdings Limited

NASDAQ:CNTB

$125.61M

Coya Therapeutics, Inc.

NASDAQ:COYA

$89.31M

Clene Inc.

NASDAQ:CLNN

$61.18M

Context Therapeutics Inc.

NASDAQ:CNTX

$56.22M

What is the latest MGNX filing?

The latest filing shown is SC 13G dated Jun 5, 2026.

How many recent filings does MGNX have?

Intrinsic Alpha currently shows 20 recent filings for MGNX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.